rs86312

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000263.4(NAGLU):​c.2209C>A​(p.Arg737Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0192 in 1,610,882 control chromosomes in the GnomAD database, including 367 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R737G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.015 ( 26 hom., cov: 31)
Exomes 𝑓: 0.020 ( 341 hom. )

Consequence

NAGLU
NM_000263.4 missense

Scores

1
2
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.635

Publications

47 publications found
Variant links:
Genes affected
NAGLU (HGNC:7632): (N-acetyl-alpha-glucosaminidase) This gene encodes an enzyme that degrades heparan sulfate by hydrolysis of terminal N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. This disease is characterized by the lysosomal accumulation and urinary excretion of heparan sulfate. [provided by RefSeq, Jul 2008]
NAGLU Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 3B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet, Myriad Women’s Health
  • Charcot-Marie-Tooth disease axonal type 2V
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029644072).
BP6
Variant 17-42544215-C-A is Benign according to our data. Variant chr17-42544215-C-A is described in ClinVar as Benign. ClinVar VariationId is 92692.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0146 (2220/152118) while in subpopulation SAS AF = 0.0309 (149/4824). AF 95% confidence interval is 0.0268. There are 26 homozygotes in GnomAd4. There are 1135 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 26 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000263.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGLU
NM_000263.4
MANE Select
c.2209C>Ap.Arg737Ser
missense
Exon 6 of 6NP_000254.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGLU
ENST00000225927.7
TSL:1 MANE Select
c.2209C>Ap.Arg737Ser
missense
Exon 6 of 6ENSP00000225927.1
ENSG00000266929
ENST00000585572.1
TSL:4
n.379+5460C>A
intron
N/A
NAGLU
ENST00000591587.1
TSL:5
c.*1178C>A
downstream_gene
N/AENSP00000467836.1

Frequencies

GnomAD3 genomes
AF:
0.0146
AC:
2221
AN:
152000
Hom.:
26
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00358
Gnomad AMI
AF:
0.0352
Gnomad AMR
AF:
0.00760
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.000580
Gnomad SAS
AF:
0.0309
Gnomad FIN
AF:
0.0269
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0210
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.0184
AC:
4553
AN:
247800
AF XY:
0.0198
show subpopulations
Gnomad AFR exome
AF:
0.00361
Gnomad AMR exome
AF:
0.00577
Gnomad ASJ exome
AF:
0.00697
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0261
Gnomad NFE exome
AF:
0.0222
Gnomad OTH exome
AF:
0.0182
GnomAD4 exome
AF:
0.0197
AC:
28690
AN:
1458764
Hom.:
341
Cov.:
74
AF XY:
0.0202
AC XY:
14625
AN XY:
725758
show subpopulations
African (AFR)
AF:
0.00257
AC:
86
AN:
33480
American (AMR)
AF:
0.00599
AC:
268
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00738
AC:
193
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.0348
AC:
3001
AN:
86256
European-Finnish (FIN)
AF:
0.0252
AC:
1268
AN:
50332
Middle Eastern (MID)
AF:
0.0121
AC:
70
AN:
5768
European-Non Finnish (NFE)
AF:
0.0205
AC:
22827
AN:
1111990
Other (OTH)
AF:
0.0161
AC:
975
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1908
3816
5724
7632
9540
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
826
1652
2478
3304
4130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0146
AC:
2220
AN:
152118
Hom.:
26
Cov.:
31
AF XY:
0.0153
AC XY:
1135
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.00357
AC:
148
AN:
41460
American (AMR)
AF:
0.00759
AC:
116
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
35
AN:
3472
East Asian (EAS)
AF:
0.000581
AC:
3
AN:
5162
South Asian (SAS)
AF:
0.0309
AC:
149
AN:
4824
European-Finnish (FIN)
AF:
0.0269
AC:
284
AN:
10576
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0210
AC:
1430
AN:
68020
Other (OTH)
AF:
0.0104
AC:
22
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
110
219
329
438
548
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0108
Hom.:
6616
TwinsUK
AF:
0.0189
AC:
70
ALSPAC
AF:
0.0195
AC:
75
ExAC
AF:
0.0192
AC:
2325
EpiCase
AF:
0.0192
EpiControl
AF:
0.0201

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
3
Mucopolysaccharidosis, MPS-III-B (3)
-
-
1
Mucopolysaccharidosis, MPS-III-B;C5569050:Charcot-Marie-Tooth disease axonal type 2V (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
T
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.088
FATHMM_MKL
Benign
0.32
N
LIST_S2
Benign
0.63
T
MetaRNN
Benign
0.0030
T
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Benign
1.9
L
PhyloP100
0.64
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.19
N
REVEL
Uncertain
0.37
Sift
Benign
0.049
D
Sift4G
Benign
0.081
T
Polyphen
0.47
P
Vest4
0.089
MPC
0.47
ClinPred
0.021
T
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.20
gMVP
0.26
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs86312; hg19: chr17-40696233; COSMIC: COSV56795278; COSMIC: COSV56795278; API